Latest Breaking News On - Chief scientific officer paul stoffels - Page 1 : vimarsana.com

© Getty Images Preliminary data show that Johnson & Johnson’s one-dose coronavirus vaccine could be effective against the delta variant (B.1.617.2) of the coronavirus. The company said in a statement that its vaccine demonstrated a “strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.” The company added that the data showed the durability of the response lasted for at least eight months. ADVERTISEMENT The data comes as the highly infectious delta variant, which was first detected in India, has become a cause for concern in the U.S. Los Angeles County and the city of St. Louis, Mo., have recommended vaccinated residents wear masks indoors amid concerns of the spread the variant. The delta variant makes up for about 25 percent of infections in the U.S. 

South africaUnited kingdomPaul stoffelsRochelle walenskyUs centers for diseaseWorld health organizationAngeles countyDisease controlChief scientific officer paul stoffelsஒன்றுபட்டது கிஂக்டம்எங்களுக்கு மையங்கள் க்கு நோய்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்ஏஞ்சல்ஸ் கவுண்டிநோய் கட்டுப்பாடு